LANXESS Mobilizes Rely+On Virkon in Response to WHO’s Mpox Emergency Alert

(IN BRIEF) LANXESS has announced that its disinfectant, Rely+On Virkon, has been proven effective against the Mpox virus, following the WHO’s declaration of an international health emergency due to rising infections in Central and East Africa. The disinfectant is crucial for preventing the spread of the virus in high-risk areas, including hospitals and public spaces. LANXESS emphasizes the importance of using scientifically validated disinfectants during such health crises.

(PRESS RELEASE) COLOGNE, 16-Aug-2024 — /EuropaWire/ — In response to the World Health Organization’s (WHO) recent declaration of an international health emergency due to rising Mpox infections in Central and East Africa, specialty chemicals company LANXESS has announced that its disinfectant, Rely+On Virkon, has been scientifically validated as effective against the Mpox virus. This critical development positions Rely+On Virkon as a key tool in preventing the spread of the virus in high-risk areas.

Independent studies have confirmed that Rely+On Virkon effectively neutralizes the Mpox virus, which was previously known as the monkeypox virus. This powerful disinfectant is specifically designed for use on hard surfaces in environments where the risk of viral transmission is high, such as hospitals, healthcare facilities, airports, and public transportation hubs.

Roy van Wel, Head of the Hygiene and Care market segment at LANXESS, emphasized the importance of utilizing proven disinfection methods during health crises: “Especially in times of rising infection rates, the choice of an effective disinfectant that has been proven to kill the target pathogen is crucial.”

Rely+On Virkon is widely recognized for its efficacy in deactivating pathogens on surfaces, thereby playing a vital role in infection control and prevention. The disinfectant’s effectiveness supports public health efforts in areas currently experiencing increased Mpox transmission, helping to protect both healthcare workers and the general public.

For more detailed information on Rely+On Virkon and its applications, please visit our website.

About LANXESS

LANXESS is a leading specialty chemicals company with sales of EUR 6.7 billion in 2023. The company currently has about 12,800 employees in 32 countries. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives and consumer protection products. LANXESS is listed in the leading sustainability indices of the Dow Jones Sustainability Index (DJSI World and Europe).

Forward-Looking Statements
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors, nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person’s officers, directors or employees accepts any liability whatsoever arising directly or indirectly from the use of this document.

LANXESS Mobilizes Rely+On Virkon in Response to WHO’s Mpox Emergency Alert

SEARCH 30,000+ EUROPEAN PRESS RELEASES

About EuropaWire

PRs by Dates

Industries & Countries

Archived PRs

Recent PRs

POPULAR TAGS

Links